WINSTON-SALEM, N.C.----Targacept, Inc. , a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics, today presented positive research findings at the 2007 Summer Meeting of the British Association for Psychopharmacology .
From: biz.yahoo.com
TM) Trial Showing Positive Effects of Mecamylamine as Augmentation Treatment for ...
Posted by Ruslan Abuzant at 3:08 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment